Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-12 5:33 pm Sale |
2025-06-10 | 13D | Vigil Neuroscience, Inc. VIGL |
Vida Ventures GP III, L.L.C. | 1,634,798 3.500% |
-1,207,202 (-42.48%) |
Filing History |
| 2025-06-09 5:48 pm Sale |
2025-06-05 | 13D | Vigil Neuroscience, Inc. VIGL |
Vida Ventures GP III, L.L.C. | 2,842,000 6.100% |
-2,200,012 (-43.63%) |
Filing History |
| 2025-06-04 5:24 pm Purchase |
2025-05-28 | 13G | Vigil Neuroscience, Inc. VIGL |
Glazer Capital, LLC | 2,513,462 5.390% |
2,513,462 (New Position) |
Filing History |
| 2025-05-30 5:04 pm Purchase |
2025-05-22 | 13G | Vigil Neuroscience, Inc. VIGL |
Beryl Capital Management LLC | 4,606,267 9.900% |
4,606,267 (New Position) |
Filing History |
| 2025-05-27 6:26 pm Sale |
2025-05-22 | 13D | Vigil Neuroscience, Inc. VIGL |
Northpond Ventures, LP | 0 0.000% |
-4,214,498 (Position Closed) |
Filing History |
| 2025-05-15 4:42 pm Purchase |
2025-03-31 | 13G | Vigil Neuroscience, Inc. VIGL |
BIOTECHNOLOGY VALUE FUND L P | 4,734,500 9.990% |
1,994,773 (+72.81%) |
Filing History |
| 2025-02-12 4:30 pm Unchanged |
2024-12-31 | 13G | Vigil Neuroscience, Inc. VIGL |
Invus Public Equities, L.P. | 1,991,038 4.900% |
0 (Unchanged) |
Filing History |
| 2024-11-14 4:19 pm Sale |
2024-09-30 | 13G | Vigil Neuroscience, Inc. VIGL |
Citadel Advisors LLC | 1,442,489 3.600% |
-719,413 (-33.28%) |
Filing History |
| 2024-11-14 10:00 am Sale |
2024-09-30 | 13G | Vigil Neuroscience, Inc. VIGL |
Deep Track Capital, LP | 1,553,996 3.920% |
-2,095,730 (-57.42%) |
Filing History |
| 2024-10-09 6:22 pm Purchase |
2024-08-13 | 13D | Vigil Neuroscience, Inc. VIGL |
Vida Ventures GP III, L.L.C. | 5,042,012 12.700% |
26,083 (+0.52%) |
Filing History |
| 2024-08-12 5:02 pm Purchase |
2024-08-01 | 13G | Vigil Neuroscience, Inc. VIGL |
Invus Public Equities, L.P. | 1,991,038 5.300% |
1,991,038 (New Position) |
Filing History |
| 2024-03-29 4:30 pm Unchanged |
2024-03-29 | 13G | Vigil Neuroscience, Inc. VIGL |
Artal Participations S.a r.l | 1,811,191 4.900% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Vigil Neuroscience, Inc. VIGL |
Citadel Advisors LLC | 2,161,902 6.000% |
-2,014 (-0.09%) |
Filing History |
| 2024-02-14 11:33 am Sale |
2023-12-31 | 13G | Vigil Neuroscience, Inc. VIGL |
Deep Track Capital, LP | 3,649,726 9.620% |
-34,893 (-0.95%) |
Filing History |
| 2024-02-12 5:31 pm Sale |
2023-12-31 | 13G | Vigil Neuroscience, Inc. VIGL |
Deerfield Mgmt, L.P. | 1,173,523 3.270% |
-878,487 (-42.81%) |
Filing History |
| 2024-02-09 5:13 pm Sale |
2023-12-31 | 13G | Vigil Neuroscience, Inc. VIGL |
Artal Participations S.a r.l | 1,811,191 5.000% |
-432,161 (-19.26%) |
Filing History |
| 2023-02-14 4:10 pm Purchase |
2022-12-31 | 13G | Vigil Neuroscience, Inc. VIGL |
Hatteras Venture Partners VI LP | 1,565,578 4.400% |
1,565,578 (New Position) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Vigil Neuroscience, Inc. VIGL |
Citadel Advisors LLC | 2,163,916 6.100% |
55,196 (+2.62%) |
Filing History |
| 2023-02-10 7:36 pm Sale |
2022-12-31 | 13G | Vigil Neuroscience, Inc. VIGL |
Artal Participations S.a r.l | 2,243,352 6.300% |
-42,222 (-1.85%) |
Filing History |
| 2023-02-10 4:31 pm Purchase |
2022-01-11 | 13D | Vigil Neuroscience, Inc. VIGL |
Vida Ventures GP III, L.L.C. | 5,015,929 14.100% |
5,015,929 (New Position) |
Filing History |